What is the recommended management approach for achalasia in elderly patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Achalasia in the Elderly

In elderly patients with achalasia, treatment selection should be based on functional status rather than chronological age: fit elderly patients should receive the same definitive treatments (pneumatic dilation, laparoscopic Heller myotomy, or POEM) as younger patients, while frail or high-risk elderly patients should be treated with botulinum toxin injection. 1, 2

Risk Stratification by Functional Status

The critical first step is determining whether the elderly patient is "fit" or "frail":

  • Fit elderly patients (good physiologic and mental health) should not have treatment tailored based on age alone and can safely undergo definitive interventions 2
  • Frail elderly patients (>60 years with significant comorbidities or high surgical risk) should be considered specifically for botulinum toxin injection 3, 1
  • Most specialized centers do not routinely modify treatment based on advanced age, as outcomes in patients >80 years are comparable to younger cohorts when appropriately selected 2

Treatment Algorithm for Fit Elderly Patients

Primary Treatment Options

For fit elderly patients, treatment should follow the same algorithm as non-elderly populations, based on achalasia subtype determined by high-resolution manometry:

Type I and Type II Achalasia:

  • Pneumatic dilation, laparoscopic Heller myotomy (LHM), or POEM are all effective options with comparable outcomes 4, 5
  • Pneumatic dilation achieves 90% efficacy in the first year, 86% in the second year, with up to one-third requiring repeat dilation within 4-6 years 4
  • Graded approach using 30-35mm balloons initially, followed by a second session 2-28 days later with 35mm balloon, with consideration of 40mm if symptoms persist 4
  • Perforation risk is 0-7% (mostly 3-4%) with mortality <1% 4

Type III Achalasia:

  • POEM should be considered the preferred treatment because it allows unlimited proximal myotomy extension (averaging 17.2 cm) tailored to the extent of spastic contractions, achieving 92% response rates 4, 5

Safety Data in Elderly Populations

  • POEM in patients ≥60 years demonstrates procedural times, complication rates, and treatment success (92.9%) comparable to younger patients, with mean follow-up of 25.2 months 6
  • LHM in patients >80 years is safe with good outcomes when performed in appropriately selected patients, though hospitalization averages 4 days without complications and 7 days with complications 2
  • POEM should be performed by experienced physicians in high-volume centers, as 20-40 procedures are needed to achieve competence 4, 5

Treatment Algorithm for Frail Elderly Patients

Botulinum toxin injection is the preferred approach for frail elderly patients:

  • Provides short-term symptom relief, most effective in elderly populations where relief can last 1-2 years with a single injection 7
  • Requires 100-200 units injected endoscopically into the lower esophageal sphincter 7
  • Has modest long-term results and frequently requires repeated injections 3
  • Critical advantage: Lower risk of gastroesophageal reflux compared to definitive treatments because it does not permanently disrupt sphincter anatomy 3

Post-Procedure Management

Reflux Prevention

  • After pneumatic dilation: Consider PPI therapy as 10-40% develop symptomatic GERD or ulcerative esophagitis 4
  • After POEM: Strongly consider pharmacologic acid suppression given increased risk of reflux and esophagitis; patients should be counseled about potential indefinite PPI therapy before the procedure 4, 5
  • After botulinum toxin: Consider PPI at standard dose by precaution, though reflux risk is lower than with definitive treatments 3
  • After LHM: Most surgeons combine myotomy with incomplete fundoplication due to common severe GERD complications 7

Perforation Monitoring

  • Suspect perforation if patients develop pain, breathlessness, fever, or tachycardia after any intervention 4, 5
  • Persistent chest pain should prompt chest x-ray and water-soluble contrast study 4
  • Most perforations occur during the first dilatation session 4
  • Elderly patients appear at higher risk for perforation 4

Anticoagulation Management

For elderly patients on anticoagulation:

  • Low thromboembolic risk: Discontinue anticoagulants with preprocedure prothrombin time 5
  • High thromboembolic risk: Discontinue oral anticoagulants, transition to IV heparin, stop 4-6 hours before procedure, resume 4-6 hours after 5

Critical Pitfalls to Avoid

  • Do not automatically default to conservative treatment based solely on age >80 years; functional status is the determining factor 2
  • Avoid endoscopic treatment as primary therapy in fit elderly patients due to high recurrence rates requiring secondary interventions in 40% of cases 2
  • Do not perform gastrectomy in elderly populations due to high complication rates 2
  • Anticipate that tight strictures may require weekly redilatation until easy passage of >14mm dilator is achieved 4

References

Research

Achalasia Treatment in Patients over 80 Years of Age: A Multicenter Survey.

Journal of laparoendoscopic & advanced surgical techniques. Part A, 2020

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnosis and Management of Achalasia Cardia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Modern management of achalasia.

Current treatment options in gastroenterology, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.